These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10869862)

  • 21. Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients.
    Addolorato G; Cibin M; Caputo F; Capristo E; Gessa GL; Stefanini GF; Gasbarrini G
    Drug Alcohol Depend; 1998 Dec; 53(1):7-10. PubMed ID: 10933335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-hydroxybutyric acid: a medicine or a drug of abuse?
    Gallimberti L
    South Med J; 2002 Aug; 95(8):793-4. PubMed ID: 12190209
    [No Abstract]   [Full Text] [Related]  

  • 24. Gamma-hydroxybutyric acid.
    Addolorato G; Gasbarrini G
    N Engl J Med; 2005 Oct; 353(15):1632-3. PubMed ID: 16224828
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological approaches to the management of alcohol addiction.
    Addolorato G; Armuzzi A; Gasbarrini G; De Lorenzi G; Ancona C; Abenavoli L; Parente A; Leggio L; Capristo E; Greco AV; Janiri L; Pozzi G; Taranto C; Caputo F; Bernardi M; Stefanini GF; Foschi FG;
    Eur Rev Med Pharmacol Sci; 2002; 6(5):89-97. PubMed ID: 12776801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma-hydroxybutyric acid in the treatment of alcohol withdrawal syndrome in patients admitted to hospital.
    Korninger C; Roller RE; Lesch OM
    Acta Med Austriaca; 2003; 30(3):83-6. PubMed ID: 14671826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia.
    Kantrowitz JT; Citrome L; Javitt DC
    Clin Ther; 2009 Jun; 31 Pt 1():1360-73. PubMed ID: 19698899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Out of addictions: Alcohol, or alcohol to alcohol].
    Simmat-Durand L; Vellut N; Lejeune C; Jauffret-Roustide M; Mougel S; Michel L; Planche M
    Encephale; 2017 Aug; 43(4):326-333. PubMed ID: 27372354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data.
    Addolorato G; Leggio L; Ferrulli A; Caputo F; Gasbarrini A
    Expert Opin Investig Drugs; 2009 May; 18(5):675-86. PubMed ID: 19379123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stress Response in Persons with Alcohol Addiction in the Context of Abstinence Duration and Disease Severity].
    Tolic I; Soyka M
    Fortschr Neurol Psychiatr; 2018 Jun; 86(6):356-367. PubMed ID: 29954018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapies for alcohol abuse. Withdrawal and treatment.
    Saitz R; O'Malley SS
    Med Clin North Am; 1997 Jul; 81(4):881-907. PubMed ID: 9222259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma-hydroxybutyric acid: an evaluation of its rewarding properties in rats and mice.
    Fattore L; Martellotta MC; Cossu G; Fratta W
    Alcohol; 2000 Apr; 20(3):247-56. PubMed ID: 10869866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABAergic medications for treating alcohol dependence.
    Caputo F; Vignoli T; Francini S; Stoppo M; Bernardi M
    J Clin Psychopharmacol; 2007 Oct; 27(5):539-40; author reply 540-2. PubMed ID: 17873704
    [No Abstract]   [Full Text] [Related]  

  • 35. γ-Hydroxybutyric acid-induced psychosis and seizures.
    Cagnin A; Pompanin S; Manfioli V; Briani C; Zambon A; Saladini M; Dam M
    Epilepsy Behav; 2011 Jun; 21(2):203-5. PubMed ID: 21530412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commenting on"a review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia," by Kantrowitzet al.
    Zvosec DL; Smith SW
    Clin Ther; 2010 Apr; 32(4):780-5. PubMed ID: 20435247
    [No Abstract]   [Full Text] [Related]  

  • 37. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.
    Kamal RM; Dijkstra BA; Loonen AJ; De Jong CA
    J Addict Med; 2016; 10(4):229-35. PubMed ID: 27310146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
    Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
    Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study.
    Caputo F; Addolorato G; Stoppo M; Francini S; Vignoli T; Lorenzini F; Del Re A; Comaschi C; Andreone P; Trevisani F; Bernardi M;
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):781-9. PubMed ID: 17611081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
    Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.